$LIVN
LivaNova PLC Stock $livn

$livn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000163969124000060 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$318.6M	$294.9M	$263.4M
YoY Change	8.4%	11.96%	9.68%
Cost Of Revenue	$99.71M	$87.52M	$89.34M
YoY Change	12.43%	-2.03%	24.54%
Gross Profit	$218.9M	$207.4M	$174.1M
YoY Change	6.66%	19.13%	3.35%
Gross Profit Margin	68.7%	70.32%	66.09%
Selling, General & Admin	$129.1M	$129.9M	$124.1M
YoY Change	2.58%	4.62%	4.73%
% of Gross Profit	58.99%	62.62%	71.3%
Research & Development	$44.74M	$45.66M	$49.99M
YoY Change	-12.49%	-8.65%	22.16%
% of Gross Profit	20.44%	22.02%	28.71%
Depreciation & Amortization	$10.41M	$6.266M	$5.956M
YoY Change	-16.6%	5.2%	5.87%
% of Gross Profit	4.75%	3.02%	3.42%
Operating Expenses	$173.9M	$175.5M	$174.1M
YoY Change	-7.44%	0.81%	9.2%
Operating Profit	$40.17M	$16.25M	-$2.342M
YoY Change	131.16%	-793.68%	-124.64%
Interest Expense	-$18.50M	$15.89M	$13.44M
YoY Change	-3734.58%	18.28%	71.39%
% of Operating Profit	-46.06%	97.83%
Other Income/Expense, Net	$104.0K	-$369.0K	-$222.0K
YoY Change	-100.83%	66.22%	534.29%
Pretax Income	$21.59M	-$34.20M	$9.768M
YoY Change	308.88%	-450.12%	75.4%
Income Tax	$5.227M	$7.717M	$2.371M
% Of Pretax Income	24.21%		24.27%
Net Earnings	$16.33M	-$41.94M	$7.370M
YoY Change	1314.11%	-669.1%	146.24%
Net Earnings / Revenue	5.13%	-14.22%	2.8%
Basic Earnings Per Share	$0.30	-$0.78	$0.14
Diluted Earnings Per Share	$0.30	-$0.78	$0.14
COMMON SHARES
Basic Shares Outstanding	54.15M shares	53.96M shares	53.56M shares
Diluted Shares Outstanding	54.59M shares	54.01M shares	53.90M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$329.2M	$309.2M	$214.3M
YoY Change	47.67%	44.25%	66.49%
Cash & Equivalents	$329.2M	$309.2M	$214.3M
Short-Term Investments
Other Short-Term Assets	$361.9M	$368.2M	$367.9M
YoY Change	-3.9%	0.09%	-4.17%
Inventory	$154.7M	$153.2M	$142.5M
Prepaid Expenses
Receivables	$200.9M	$209.4M	$178.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.047B	$1.040B	$903.0M
YoY Change	11.13%	15.17%	11.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$158.1M	$152.2M	$149.1M
YoY Change	-13.98%	2.13%	0.75%
Goodwill	$766.4M	$771.8M	$774.4M
YoY Change	-1.65%	-0.34%	-13.62%
Intangibles	$248.2M	$253.9M	$364.1M
YoY Change	-30.56%	-30.25%	-6.76%
Long-Term Investments	$17.20M	$22.68M	$21.47M
YoY Change	-20.83%	5.61%	28.22%
Other Assets	$14.36M	$13.37M	$13.95M
YoY Change	-75.08%	-4.2%	-22.15%
Total Long-Term Assets	$1.406B	$1.420B	$1.392B
YoY Change	0.48%	1.99%	-13.4%
TOTAL ASSETS
Total Short-Term Assets	$1.047B	$1.040B	$903.0M
Total Long-Term Assets	$1.406B	$1.420B	$1.392B
Total Assets	$2.453B	$2.460B	$2.295B
YoY Change	4.77%	7.18%	-5.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$81.32M	$75.94M	$75.73M
YoY Change	3.98%	0.28%	2.45%
Accrued Expenses	$97.97M	$94.03M	$96.35M
YoY Change	-22.89%	-2.41%	4.7%
Deferred Revenue	$10.23M	$8.113M	$11.72M
YoY Change	-7.4%	-30.76%	34.35%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$19.11M	$19.07M	$21.56M
YoY Change	0.16%	-11.55%	1146.79%
Total Short-Term Liabilities	$303.0M	$327.8M	$316.1M
YoY Change	5.14%	3.68%	2.67%
LONG-TERM LIABILITIES
Long-Term Debt	$605.4M	$604.8M	$520.2M
YoY Change	6.6%	16.25%	14.13%
Other Long-Term Liabilities	$44.90M	$48.09M	$46.27M
YoY Change	-80.97%	3.94%	-7.03%
Total Long-Term Liabilities	$650.3M	$652.8M	$566.5M
YoY Change	-19.1%	15.25%	12.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$303.0M	$327.8M	$316.1M
Total Long-Term Liabilities	$650.3M	$652.8M	$566.5M
Total Liabilities	$1.211B	$1.238B	$1.068B
YoY Change	9.96%	15.97%	-5.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$992.1M	-$1.008B	-$976.7M
YoY Change	1.7%	3.25%	9.15%
Common Stock	$2.288B	$2.276B	$2.245B
YoY Change	1.59%	1.35%	1.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$195.0K	$481.0K	$319.0K
YoY Change	105.26%	50.78%	-48.47%
Treasury Stock Shares
Shareholders Equity	$1.243B	$1.222B	$1.227B
YoY Change
Total Liabilities & Shareholders Equity	$2.453B	$2.460B	$2.295B
YoY Change	4.77%	7.18%	-5.05%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$16.33M	-$41.94M	$7.370M
YoY Change	1314.11%	-669.1%	146.24%
Depreciation, Depletion And Amortization	$10.41M	$6.266M	$5.956M
YoY Change	-16.6%	5.2%	5.87%
Cash From Operating Activities	$43.22M	$9.981M	$20.76M
YoY Change	-340.95%	-51.92%	-19.62%
INVESTING ACTIVITIES
Capital Expenditures	$12.20M	$6.398M	$7.685M
YoY Change	115.62%	-16.75%	47.36%
Acquisitions
YoY Change
Other Investing Activities	-$335.0K	-$35.00K	-$1.337M
YoY Change	-66.37%	-97.38%	400.75%
Cash From Investing Activities	-$12.54M	-$6.363M	-$11.48M
YoY Change	88.38%	-44.59%	109.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$234.4M	$1.875M
YoY Change		12400.0%
Cash From Financing Activities	-11.85M	$37.15M	-$5.235M
YoY Change	-132.9%	-809.59%	-102.44%
NET CHANGE
Cash From Operating Activities	43.22M	$9.981M	$20.76M
Cash From Investing Activities	-12.54M	-$6.363M	-$11.48M
Cash From Financing Activities	-11.85M	$37.15M	-$5.235M
Net Change In Cash	18.84M	$37.81M	$7.340M
YoY Change	64.9%	415.14%	-96.87%
FREE CASH FLOW
Cash From Operating Activities	$43.22M	$9.981M	$20.76M
Capital Expenditures	$12.20M	$6.398M	$7.685M
Free Cash Flow	$31.02M	$3.583M	$13.07M
YoY Change	-231.45%	-72.59%	-36.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	87522000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	89335000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	207390000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	174083000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	129863000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	124129000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45664000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49986000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-15617000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2310000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	16246000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2342000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	15893000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	13437000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25482000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	-9071000	usd
CY2023Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	25547000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-34200000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9768000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7717000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2371000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-26000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-27000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-41943000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.78
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54008000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53617000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54008000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53900000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-41943000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	-966000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-966000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-17323000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	8053000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-17323000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7087000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-59266000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14457000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	309191000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	266504000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	306492000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	311368000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11026000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12019000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	209431000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	215072000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	153176000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	147887000	usd
CY2024Q1	us-gaap	Prepaid Taxes PrepaidTaxes	22543000	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	20145000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	39184000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27182000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1040017000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	988158000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	152237000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154181000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	771817000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	782941000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	253927000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	261178000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	50260000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	50845000	usd
CY2024Q1	us-gaap	Investments Investments	22675000	usd
CY2023Q4	us-gaap	Investments Investments	22843000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	113687000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	118858000	usd
CY2024Q1	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	41617000	usd
CY2023Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	38496000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13365000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12063000	usd
CY2024Q1	us-gaap	Assets Assets	2459602000	usd
CY2023Q4	us-gaap	Assets Assets	2429563000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	19704000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	18111000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	75944000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	80845000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	94029000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	107301000	usd
CY2024Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	16980000	usd
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	10756000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	29761000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	23340000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	91353000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	94630000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	327771000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	334983000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	604753000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	568543000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	80769000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	80902000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10974000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11567000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43724000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45388000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	17062000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	17254000	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	104920000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	45569000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48092000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	47729000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1238065000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1151935000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54295837	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54148808	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53942151	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53918222	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	82975000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	82533000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2192676000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2189517000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-45206000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27883000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1008427000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-966484000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	147029	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	23929	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	481000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	55000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1221537000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1277628000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2459602000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2429563000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-41943000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25482000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	-11598000	usd
CY2023Q1	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	26281000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10226000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10579000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	6266000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	5956000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4900000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5019000	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	4329000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6355000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4800000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-76000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2544000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2642000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-133000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4827000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	534000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	108000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1991000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7558000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8146000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11342000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8945000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3838000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-15576000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	21378000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6887000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	972000	usd
CY2024Q1	livn	Increase Decrease In Litigation Reserve IncreaseDecreaseInLitigationReserve	6235000	usd
CY2023Q1	livn	Increase Decrease In Litigation Reserve IncreaseDecreaseInLitigationReserve	-10254000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9981000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20757000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6398000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7685000	usd
CY2024Q1	livn	Purchases Of Investments PurchasesOfInvestments	0	usd
CY2023Q1	livn	Purchases Of Investments PurchasesOfInvestments	5136000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-35000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1337000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6363000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11484000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	335513000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	234375000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1875000	usd
CY2024Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	38953000	usd
CY2023Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2024Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	31637000	usd
CY2023Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	usd
CY2024Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	22523000	usd
CY2023Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
CY2024Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	13750000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	316000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1577000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1893000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt Maturing In More Than Three Months RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	0	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt Maturing In More Than Three Months RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	1974000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	725000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	35000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	191000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37147000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5235000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2954000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3302000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37811000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7340000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	577872000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515618000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	615683000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	522958000	usd
	livn	Cybersecurity Incident Related Expenses CybersecurityIncidentRelatedExpenses	5400000	usd
CY2024Q1	livn	Cybersecurity Incident Related Expenses CybersecurityIncidentRelatedExpenses	2800000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	911000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	9225000	usd
CY2024Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	3310000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	6826000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	9225000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	623820000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	586027000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	19067000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	17484000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	604753000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	568543000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25500000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	42912000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	104920000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	38496000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	49452000	usd
CY2016	livn	Reimbursed Legal Fees ReimbursedLegalFees	292000	eur
CY2024Q1	livn	Reimbursed Legal Fees ReimbursedLegalFees	315403000	usd
CY2021Q1	livn	Utilities Operating Expense Environmental Maintenance UtilitiesOperatingExpenseEnvironmentalMaintenance	1000000	eur
CY2024Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	16980000	usd
CY2024Q1	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	3035000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1277628000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3175000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-41943000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-17323000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1221537000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1207624000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5260000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7087000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1227341000	usd
CY2024Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-17323000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
CY2024Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-17323000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-17323000	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	7620000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	7620000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	533000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	533000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7087000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	100000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.226
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.243
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.78
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-41943000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54008000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53617000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	283000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54008000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53900000	shares
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q1	livn	Number Of Geographic Regions In Which Entity Operates NumberOfGeographicRegionsInWhichEntityOperates	3	geographic_region
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	294912000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263418000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	16246000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2342000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	15893000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	13437000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25482000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	-9071000	usd
CY2023Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	25547000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-34200000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9768000	usd
CY2024Q1	us-gaap	Assets Assets	2459602000	usd
CY2023Q4	us-gaap	Assets Assets	2429563000	usd
CY2024Q1	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	6447000	usd
CY2023Q1	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	7851000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	782941000	usd
CY2024Q1	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	-11124000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	771817000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	152237000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154181000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	76782000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	81878000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15964000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12901000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	60430000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	53108000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	153176000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	147887000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	25000000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24400000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	19961000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	17794000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8578000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8362000	usd
CY2024Q1	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	8447000	usd
CY2023Q4	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	8223000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8113000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10725000	usd
CY2024Q1	livn	Interest Payable Current Net InterestPayableCurrentNet	7985000	usd
CY2023Q4	livn	Interest Payable Current Net InterestPayableCurrentNet	7840000	usd
CY2024Q1	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	6705000	usd
CY2023Q4	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	4464000	usd
CY2024Q1	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	4601000	usd
CY2023Q4	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	911000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4146000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4441000	usd
CY2024Q1	livn	Research And Development Costs Payable Current ResearchAndDevelopmentCostsPayableCurrent	3099000	usd
CY2023Q4	livn	Research And Development Costs Payable Current ResearchAndDevelopmentCostsPayableCurrent	2462000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	13750000	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3883000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22394000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	24446000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	94029000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	107301000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14100000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15300000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-922000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	222000	usd
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	7021000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	4536000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-369000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-222000	usd
CY2024Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	-9071000	usd
CY2023Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	25547000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	309191000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	266504000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	306492000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	311368000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	615683000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	577872000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	306500000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	311400000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001639691-24-000060-index-headers.html	Edgar Link	pending
0001639691-24-000060-index.html	Edgar Link	pending
0001639691-24-000060.txt	Edgar Link	pending
0001639691-24-000060-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
livanova-offerletterxvla.htm	Edgar Link	pending
livanova-offerletterxvla001.jpg	Edgar Link	pending
livanova-offerletterxvla002.jpg	Edgar Link	pending
livanova-offerletterxvla003.jpg	Edgar Link	pending
livanova-offerletterxvla004.jpg	Edgar Link	pending
livanova-offerletterxvla005.jpg	Edgar Link	pending
livanova-offerletterxvla006.jpg	Edgar Link	pending
livanova-offerletterxvla007.jpg	Edgar Link	pending
livanova-offerletterxvla008.jpg	Edgar Link	pending
livn-20240331.htm	Edgar Link	pending
livn-20240331.xsd	Edgar Link	pending
livn-20240331_g1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
livn-20240331_cal.xml	Edgar Link	unprocessable
livn-20240331_def.xml	Edgar Link	unprocessable
livn-20240331_lab.xml	Edgar Link	unprocessable
livn-20240331_pre.xml	Edgar Link	unprocessable
livn-20240331_htm.xml	Edgar Link	completed
livn-2024331xex311.htm	Edgar Link	pending
livn-2024331xex312.htm	Edgar Link	pending
livn-2024331xex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIVN
LivaNova PLC Stock $livn

2024 Q2 Form 10-Q Financial Statement

#000163969124000060 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN LivaNova PLC Stock $livn

2024 Q2 Form 10-Q Financial Statement

#000163969124000060 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN
LivaNova PLC Stock $livn